Arete Wealth Advisors, LLC Acadia Pharmaceuticals Inc Transaction History
Arete Wealth Advisors, LLC
- $1.31 Billion
- Q1 2025
A detailed history of Arete Wealth Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 13,625 shares of ACAD stock, worth $308,333. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,625
Previous 13,700
0.55%
Holding current value
$308,333
Previous $251,000
9.96%
% of portfolio
0.02%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding ACAD
# of Institutions
353Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$970 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$344 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$273 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$193 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$158 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.66B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...